SEA0400 is a novel and selective inhibitor of the Na+-Ca2+ exchanger with IC50 of 5-33nM (inhibiting Na+-dependent Ca2+ uptake in cultured neurons, astrocytes, and microglia).
信号通路
Transmembrane Transporters
靶点
NCX
-
-
-
-
IC50
5-33nM
-
-
-
-
体外研究
SEA0400, a specific Na+/Ca2+ exchange (NCX) inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease and attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. SEA0400 will be a powerful tool for further studies on the role of NCX in the heart and the therapeutic potential of its inhibition.
体内研究
N/A
临床实验
N/A
特征
N/A
相关实验数据(此数据来自于公开文献,信裕生物并不保证其有效性):
酶活性检测实验
方法
N/A
细胞实验
细胞系
N/A
浓度
N/A
处理时间
N/A
方法
N/A
动物实验
动物模型
N/A
配制
N/A
剂量
N/A
给药方式
N/A
参考文献: 1. Matsuda T, et al. J Pharmacol Exp Ther. 2001 Jul, 298(1), 249-56.
2. Nashida T, Takuma K, Fukuda S, et al. Neurochem Int. 2011 Aug, 59(1), 51-8.
3. Ago Y, Kawasaki T, Nashida T, et al. Neuropharmacology. 2011 Dec, 61(8), 1441-51.
包装清单: